Kynurenine and probenecid inhibit pentylenetetrazol- and NMDLA-induced seizures and increase kynurenic acid concentrations in the brain.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Brain Research Bulletin

• Publication date

  1992-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0361-9230(92)90184-YPMID 1596743
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of NMDA- and strychnine-insensitive glycine site antagonists on NMDA-mediated convulsions and learning

  2005cited by this paper
• The influence of strychnine-insensitive glycine receptor agonists and antagonists on generalized seizure thresholds.

  1991cited by this paper
• Two kynurenine aminotransferases in human brain.

  1991cited by this paper
• Blood–Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism

  1991cited by this paper
• Comparative behavioral and pharmacological studies with centrally administered kynurenine and kynurenic acid in rats.

  1991cited by this paper
• 7-Chlorokynurenic acid, a strychnine-insensitive glycine receptor antagonist, inhibits limbic seizure kindling.

  1990cited by this paper
• Modulation of seizure susceptibility in the mouse by the strychnine‐insensitive glycine recognition site of the NMDA receptor/ion channel complex

  1990cited by this paper
• Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors

  1990cited by this paper
• Kynurenine Pathway Measurements in Huntington's Disease Striatum: Evidence for Reduced Formation of Kynurenic Acid

  1990cited by this paper
• Measurement of kynurenic acid in mammalian brain extracts and cerebrospinal fluid by high-performance liquid chromatography with fluorometric and coulometric electrode array detection.

  1990cited by this paper
• Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects.

  1990cited by this paper
• Excitatory amino acid receptors in epilepsy.

  1990cited by this paper
• Influence of kynurenine treatment on open-field activity, elevated plus-maze, avoidance behaviors and seizures in rats.

  1990cited by this paper
• Uptake of Kynurenine into Rat Brain Slices

  1990cited by this paper
• A Glycine Site Associated with N‐Methyl‐d‐Aspartic Acid Receptors: Characterization and Identification of a New Class of Antagonists

  1989cited by this paper
• Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor.

  1988cited by this paper
• NMDA receptors and ligands in the vertebrate CNS.

  1988cited by this paper
• Identification and quantification of kynurenic acid in human brain tissue.

  1988cited by this paper
• Glutamate neurotoxicity and diseases of the nervous system.

  1988cited by this paper
• Presence of Kynurenic Acid in the Mammalian Brain

  1988cited by this paper
• Identification and measurement of kynurenic acid in the rat brain and other organs.

  1988cited by this paper
• Kynurenate and FG9041 have both competitive and non-competitive antagonist actions at excitatory amino acid receptors.

  1988cited by this paper
• Kynurenate inhibition of cell excitation decreases stroke size and deficits

  1987cited by this paper
• Kynurenic acid and quinolinic acid act at N-methyl-D-aspartate receptors in the rat hippocampus.

  1986cited by this paper
• Inhibition of excitatory neurotransmission with kynurenate reduces brain edema in neonatal anoxia.

  1986cited by this paper
• Kynurenic acid-induced protection of neurochemical and behavioural deficits produced by quinolinic acid injections into the nucleus basalis of rats.

  1986cited by this paper
• Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid

  1986cited by this paper
• Actions of kynurenic acid and quinolinic acid in the rat hippocampus in vivo.

  1985cited by this paper
• Anticonvulsant action of β-kainic acid in mice. Is β-kainic acid an N-methyl-d-aspartate antagonist?

  1985cited by this paper
• Anticonvulsant action of beta-kainic acid in mice. Is beta-kainic acid an N-methyl-D-aspartate antagonist?

  1985cited by this paper
• Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid.

  1984cited by this paper
• Kynurenic acid inhibits synaptic and acidic amino acid-induced responses in the rat hippocampus and spinal cord.

  1983cited by this paper
• An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid.

  1982cited by this paper
• Convulsant action of intracerebroventricularly administered l-kynurenine sulphate, quinolinic acid and other derivatives of succinic acid, and effects of amino acids: structure-activity relationships.

  1982cited by this paper
• SYNTHESIS AND METABOLISM OF l‐KYNURENINE IN RAT BRAIN

  1978cited by this paper
• Fluorometric assay of proteins in the nanogram range.

  1973cited by this paper
• 'Benemid,' p-(di-n-propylsulfamyl)-benzoic acid; its renal affinity and its elimination.

  1951cited by this paper
• THE CONSTITUTION OF KYNURENIC ACID

  1914cited by this paper
• Die Entstehung der Kynurensäure.

  year unknowncited by this paper

• Antiseizure Effects of Mirtazapine in a Rat Model of Status Epilepticus Via Cannabinoid Receptor Modulation

  2025cites this paper
• Ketogenic diet for infantile epileptic spasms.

  2025cites this paper
• Neuroactive Kynurenines as Pharmacological Targets: New Experimental Tools and Exciting Therapeutic Opportunities

  2024cites this paper
• The Biology and Biochemistry of Kynurenic Acid, a Potential Nutraceutical with Multiple Biological Effects

  2024cites this paper
• Glucocorticoid Hormones as Modulators of the Kynurenine Pathway in Chronic Pain Conditions

  2023cites this paper
• Increased glycine contributes to synaptic dysfunction and early mortality in Nprl2 seizure model

  2022cites this paper
• Influx of kynurenine into the brain is involved in the reduction of ethanol consumption induced by Ro 61‐8048 after chronic intermittent ethanol in mice

  2022cites this paper
• Organic anion transporter 1 is an HDAC4-regulated mediator of nociceptive hypersensitivity in mice

  2022cites this paper
• Kynurenic Acid Analog Attenuates the Production of Tumor Necrosis Factor-α, Calgranulins (S100A 8/9 and S100A 12), and the Secretion of HNP1–3 and Stimulates the Production of Tumor Necrosis Factor-Stimulated Gene-6 in Whole Blood Cultures of Patients With Rheumatoid Arthritis

  2021influential citation
• Subchronic N-acetylcysteine Treatment Decreases Brain Kynurenic Acid Levels and Improves Cognitive Performance in Mice

  2021cites this paper
• Increased kynurenine concentration attenuates serotonergic neurotoxicity induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats through activation of aryl hydrocarbon receptor.

  2021cites this paper
• Probenecid Increases the Concentration of 7-Chlorokynurenic Acid Derived from the Prodrug 4-Chlorokynurenine within the Prefrontal Cortex.

  2020cites this paper
• Quinolinate as a Marker for Kynurenine Metabolite Formation and the Unresolved Question of NAD+ Synthesis During Inflammation and Infection

  2020cites this paper
• The therapeutic impact of new migraine discoveries.

  2019cites this paper
• The Opposite Effects of Kynurenic Acid and Different Kynurenic Acid Analogs on Tumor Necrosis Factor-α (TNF-α) Production and Tumor Necrosis Factor-Stimulated Gene-6 (TSG-6) Expression

  2019cites this paper
• Exploratory Application of Neuropharmacometabolomics in Severe Childhood Traumatic Brain Injury*

  2018cites this paper
• Mitochondria, Oxidative Stress and the Kynurenine System, with a Focus on Ageing and Neuroprotection

  2018cites this paper
• Biofluid Biomarkers in Huntington's Disease.

  2018cites this paper
• The prescribable drugs with efficacy in experimental epilepsies (PDE3) database for drug repurposing research in epilepsy

  2018cites this paper
• Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases

  2017cites this paper
• Kynurenines and PACAP in Migraine: Medicinal Chemistry and Pathogenetic Aspects.

  2017cites this paper
• Kynurenines, Gender and Neuroinflammation; Showcase Schizophrenia

  2016cites this paper
• A Perspective on the Safety of Supplemental Tryptophan Based on Its Metabolic Fates.

  2016cites this paper
• Immune response effect on dopamine production during Toxoplasma gondii infection

  2016cites this paper
• Brain Aging and Disorders of the Central Nervous System: Kynurenines and Drug Metabolism.

  2016cites this paper
• The Role of the Kynurenine Pathway in Neurodegenerative Diseases

  2015cites this paper
• A single-run liquid chromatography mass spectrometry method to quantify neuroactive kynurenine pathway metabolites in rat plasma.

  2015cites this paper
• Drug Resistance in Cortical and Hippocampal Slices from Resected Tissue of Epilepsy Patients: No Significant Impact of P-Glycoprotein and Multidrug Resistance-Associated Proteins

  2015cites this paper
• Exposure to Kynurenic Acid during Adolescence Increases Sign-Tracking and Impairs Long-Term Potentiation in Adulthood

  2015cites this paper
• The Role of Kynurenine Pathway in Pain and Migraine

  2015cites this paper
• Novel kynurenic acid analogues in the treatment of migraine and neurodegenerative disorders: preclinical studies and pharmaceutical design.

  2015cites this paper
• Effect of probenecid on the pain-related behaviour and morphological markers in orofacial formalin test of the rat.

  2015cites this paper
• Targeting the Broadly Pathogenic Kynurenine Pathway

  2015cites this paper
• Reduced-intensity conditioning hematopoietic cell transplantation is an effective treatment for patients with SLAM-associated protein deficiency/X-linked lymphoproliferative disease type 1.

  2014cites this paper
• L-Kynurenine/Aryl Hydrocarbon Receptor Pathway Mediates Brain Damage After Experimental Stroke

  2014cites this paper
• B7 costimulation and intracellular indoleamine-2,3-dioxygenase (IDO) expression in peripheral blood of healthy pregnant and non-pregnant women

  2014cites this paper
• Interactions Between Prenatal Kynurenic Acid Exposure and Adolescent Brain Development in the Emergence of Cognitive Deficits in Schizophrenia

  2014cites this paper
• Endogenous Kynurenic Acid and Neurotoxicity

  2014cites this paper
• Modulatory effect of synthetic kynurenic acid derivatives on the nitroglycerin-induced trigeminal activation and sensitization in rats

  2014cites this paper
• B7 costimulation and intracellular indoleamine 2,3-dioxygenase expression in umbilical cord blood and adult peripheral blood.

  2014cites this paper
• Assessment of the anti-inflammatory activity of potentially bioactive compunds by intravital microcircuilatory analysis

  2013influential citation
• The kynurenine pathway: a missing piece in the puzzle of valproate action?

  2013cites this paper
• Targeted siRNA Delivery Methods for RNAi-Based Therapies

  2013cites this paper
• Structural dynamics and ligand binding in kynurenine-3- monooxygenase

  2013cites this paper
• Influence of Ovarian Hormones on Cortical Spreading Depression and Its Suppression by L-kynurenine in Rat

  2013cites this paper
• Probenecid: novel use as a non-injurious positive inotrope acting via cardiac TRPV2 stimulation.

  2012cites this paper
• The role of kynurenines in the pathomechanism of amyotrophic lateral sclerosis and multiple sclerosis: therapeutic implications

  2012cites this paper
• Mitochondrial disturbances, tryptophan metabolites and neurodegeneration: medicinal chemistry aspects.

  2012cites this paper
• Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery

  2012cites this paper
• The kynurenine system and immunoregulation

  2012cites this paper
• A novel kynurenic acid analog (SZR104) inhibits pentylenetetrazole-induced epileptiform seizures. An electrophysiological study

  2012cites this paper
• Where does a migraine attack originate? In the brainstem

  2012cites this paper
• Effect of systemic kynurenine on cortical spreading depression and its modulation by sex hormones in rat.

  2012cites this paper
• Migraine is a neuronal disease

  2011cites this paper
• Different inhibitory effects of kynurenic acid and a novel kynurenic acid analogue on tumour necrosis factor-α (TNF-α) production by mononuclear cells, HMGB1 production by monocytes and HNP1-3 secretion by neutrophils

  2011cites this paper
• Kynurenine Metabolites and Migraine: Experimental Studies and Therapeutic Perspectives

  2011cites this paper
• Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy.

  2011influential citation
• G-protein coupled receptor 35 (GPR35) activation and inflammatory pain: Studies on the antinociceptive effects of kynurenic acid and zaprinast.

  2011cites this paper
• The pathophysiological roles of kynurenic acid and cytokines in psychiatric illness

  2011cites this paper
• Protective effect of systemic L-kynurenine and probenecid administration on behavioural and morphological alterations induced by toxic soluble amyloid beta (25-35) in rat hippocampus.

  2010cites this paper
• Blood levels of kynurenines, interleukin‐23 and soluble human leucocyte antigen‐G at different stages of Huntington’s disease

  2010cites this paper
• Medical treatment of Parkinson's disease: today and the future.

  2010cites this paper
• EFECTO DE LOS PRETRATAMIENTOS SOLOS Y COMBINADO DE PROBENECID Y KINURENINA SOBRE EL DAÑO OXIDATIVO EN UN MODELO EXPERIMENTAL DE LA

  2010cites this paper
• N‐Methyl‐d‐aspartate receptor antagonism decreases motility and inflammatory activation in the early phase of acute experimental colitis in the rat

  2010cites this paper
• A novel kynurenic acid analogue: a comparison with kynurenic acid. An in vitro electrophysiological study

  2010cites this paper
• 5 Kynurenines in the Brain: Preclinical and Clinical Studies, Therapeutic Considerations

  2009cites this paper
• The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection.

  2009cites this paper
• l-kynurenine combined with probenecid and the novel synthetic kynurenic acid derivative attenuate nitroglycerin-induced nNOS in the rat caudal trigeminal nucleus.

  2009cites this paper
• Syntheses, transformations and pharmaceutical applications of kynurenic acid derivatives.

  2009cites this paper
• Modulatory effects of probenecid on the nitroglycerin-induced changes in the rat caudal trigeminal nucleus.

  2009cites this paper
• Protective compounds in animal models of trigeminal activation and neurodegeneration

  2009cites this paper
• Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia.

  2009cites this paper
• Recent findings in kynurenine research in the field of experimental epilepsy and stroke models : Electrophysiological, behavioural and histological studies

  2009cites this paper
• L-kynurenine: Metabolism and mechanism of neuroprotection

  2008cites this paper
• Indoleamine 2,3-dioxygenase-dependent tryptophan metabolites contribute to tolerance induction during allergen immunotherapy in a mouse model.

  2008cites this paper
• Rapid communication The kynurenate analog SZR-72 prevents the nitroglycerol-induced increase of c-fos immunoreactivity in the rat caudal trigeminal nucleus : Comparative studies of the effects of SZR-72 and kynurenic acid

  2008cites this paper
• Comparative Proteome Analysis of Thalamus and Cortex from Rats Subchronically Treated with Kynurenine and Probenecid.

  2008cites this paper
• Possible glutamatergic and lipid signalling mechanisms in ECT-induced retrograde amnesia: experimental evidence for involvement of COX-2, and review of literature.

  2008cites this paper
• Kynurenine diminishes the ischemia-induced histological and electrophysiological deficits in the rat hippocampus.

  2008cites this paper
• Allergen specific immunotherapy: The future cure for allergic asthma. Mechanisms and improvement in a mouse model

  2007cites this paper
• Prevention of electrical stimulation-induced increase of c-fos immunoreaction in the caudal trigeminal nucleus by kynurenine combined with probenecid.

  2007cites this paper
• Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.

  2007cites this paper
• Kynurenic acid inhibits intestinal hypermotility and xanthine oxidase activity during experimental colon obstruction in dogs

  2007cites this paper
• Kynurenines in neurological disorders

  2007cites this paper
• Subchronic treatment with kynurenine and probenecid: effects on prepulse inhibition and firing of midbrain dopamine neurons

  2006cites this paper
• Kynurenine in combination with probenecid mitigates the stimulation-induced increase of c-fos immunoreactivity of the rat caudal trigeminal nucleus in an experimental migraine model

  2006cites this paper
• Neuroprotective effects of kynurenine and related compounds. Electrophysiological and behavioral studies

  2006cites this paper
• Kynurenines, Parkinson's disease and other neurodegenerative disorders: preclinical and clinical studies.

  2006cites this paper
• Tryptophan metabolism and oxidative stress in patients with Huntington's disease

  2005cites this paper
• Kynurenate and 7‐Chlorokynurenate Formation in Chronically Epileptic Rats

  2005cites this paper
• Systemically administered glucosamine-kynurenic acid, but not pure kynurenic acid, is effective in decreasing the evoked activity in area CA1 of the rat hippocampus.

  2005cites this paper
• Kynurenine administered together with probenecid markedly inhibits pentylenetetrazol-induced seizures. An electrophysiological and behavioural study.

  2004cites this paper
• Kynurenines in neurodegenerative disorders: therapeutic consideration.

  2004cites this paper
• Comparative study on the effects of kynurenic acid and glucosamine-kynurenic acid.

  2004cites this paper
• Micromolar Brain Levels of Kynurenic Acid are Associated with a Disruption of Auditory Sensory Gating in the Rat

  2003influential citation
• Effect of Systemic Administration of L‐Kynurenine on Corticocerebral Blood Flow under Normal and Ischemic Conditions of the Brain in Conscious Rabbits

  2003cites this paper
• Presynaptic kynurenate‐sensitive receptors inhibit glutamate release

  2001cites this paper
• Increased cortical kynurenate content in schizophrenia.

  2001cites this paper
• Kynurenergic manipulations influence excitatory synaptic function and excitotoxic vulnerability in the rat hippocampus in vivo.

  2000cites this paper
• Kynurenine metabolism in Alzheimer's disease

  1999cites this paper